Evidence of SEMS in AVB.
| Year | n=patients | SEMS successfully deployed (%) | Immediate haemostasis (%) | Rebleeding (%) | SEMS migration (%) | Median (range) days to stent removal | Mortality follow-up period | |
|---|---|---|---|---|---|---|---|---|
| Hubmann et al | 2006 | 15 | 100 | 100 | 0 | 13 | 5 (1–14) | 20% 60 days |
| Zehetner et al | 2008 | 34 | 100 | 100 | 0 | 18 | 5* (1–14) | 29% 60 days |
| Wright et al | 2010 | 10 | 90 | 70 | 14 | NR | 9 (6–14) | 50% 42 days |
| Dechene et al | 2012 | 8 | 100 | 100 | 38 | 0 | 11 (7–14) | 75% 60 |
| Holster et al | 2013 | 5 | 100 | 100 | 20 | 20 | 11 (6–214) | 40% 180 days |
| Zakaria et al | 2013 | 16 | 94 | 88 | 0 | 38 | NR (2–4) | 25% NR |
*Represents mean (not median).
NR, not reported; SEMS, self-expandable metallic stents.